NOVARTIS AG (NVSEF)
Clinical trial NCT05469360 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-01-02 → 2027-09-24 3. primary completion date: 2026-09-11 → 2026-07-30 4. enrollment: 36 → 38 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical